SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001437749-22-010078
Filing Date
2022-04-28
Accepted
2022-04-28 16:04:12
Documents
5
Period of Report
2022-06-07

Document Format Files

Seq Description Document Type Size
1 FORM DEF 14A vxrt20220418_def14a.htm DEF 14A 1097962
2 image01.jpg GRAPHIC 25454
3 image02.jpg GRAPHIC 27924
4 pc01.jpg GRAPHIC 107448
5 pc02.jpg GRAPHIC 82642
  Complete submission text file 0001437749-22-010078.txt   1434636
Mailing Address 170 HARBOR WAY, SUITE 300 SOUTH SAN FRANCISCO CA 94080
Business Address 170 HARBOR WAY, SUITE 300 SOUTH SAN FRANCISCO CA 94080 (650) 550-3500
Vaxart, Inc. (Filer) CIK: 0000072444 (see all company filings)

IRS No.: 591212264 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-35285 | Film No.: 22866416
SIC: 2836 Biological Products, (No Diagnostic Substances)